89 related articles for article (PubMed ID: 3312045)
1. Changes in the broncho-alveolar lavage fluid in smokers and patients with chronic obstructive lung disease.
Terpstra GK; Wassink GA; Huidekoper HJ
Int J Clin Pharmacol Res; 1987; 7(5):357-61. PubMed ID: 3312045
[TBL] [Abstract][Full Text] [Related]
2. Changes in alveolar macrophage enzyme content and activity in smokers and patients with chronic obstructive lung disease.
Terpstra GK; De Weger RA; Wassink GA; Kreuknit J; Huidekoper HJ
Int J Clin Pharmacol Res; 1987; 7(4):273-7. PubMed ID: 3596869
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil chemotactic activity produced by normal and activated human bronchoalveolar lavage cells.
Sibille Y; Naegel GP; Merrill WW; Young KR; Care SB; Reynolds HY
J Lab Clin Med; 1987 Nov; 110(5):624-33. PubMed ID: 2822825
[TBL] [Abstract][Full Text] [Related]
4. Effects of ozone on normal and potentially sensitive human subjects. Part II: Airway inflammation and responsiveness to ozone in nonsmokers and smokers.
Frampton MW; Morrow PE; Torres A; Voter KZ; Whitin JC; Cox C; Speers DM; Tsai Y; Utell MJ
Res Rep Health Eff Inst; 1997 Jun; (78):39-72; discussion 81-99. PubMed ID: 9387196
[TBL] [Abstract][Full Text] [Related]
5. Bronchoalveolar lavage in smokers: quantification of alveolar macrophages and neutrophils as markers of bronchial obstruction.
Jimenez Ruiz CA; Rajas O; Ruiz A; Ramos A; Florez S; Ramos L; Solano S; Fornies E
In Vivo; 1998; 12(4):427-30. PubMed ID: 9706495
[TBL] [Abstract][Full Text] [Related]
6. Human alveolar macrophages from smokers have an impaired capacity to secrete LTB4 but not other chemotactic factors.
Wieslander E; Linden M; Håkansson L; Eklund A; Blaschke E; Brattsand R; Venge P
Eur J Respir Dis; 1987 Oct; 71(4):263-72. PubMed ID: 2826202
[TBL] [Abstract][Full Text] [Related]
7. [C5 contents and neutrophil chemotactic activities in bronchiolar and alveolar regions].
Hayashi H; Ozaki T; Nakamura Y; Kamei T; Kawaji K; Tani K; Noda Y; Ogushi F; Yasuoka S; Ogura T
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Jun; 29(6):677-84. PubMed ID: 1895584
[TBL] [Abstract][Full Text] [Related]
8. Urinary levels of bombesin-like peptides in asymptomatic cigarette smokers: a potential risk marker for smoking-related diseases.
Aguayo SM; King TE; Kane MA; Sherritt KM; Silvers W; Nett LM; Petty TL; Miller YE
Cancer Res; 1992 May; 52(9 Suppl):2727s-2731s. PubMed ID: 1563004
[TBL] [Abstract][Full Text] [Related]
9. Lower airway bacterial colonization in asymptomatic smokers and smokers with chronic bronchitis and recurrent exacerbations.
Qvarfordt I; Riise GC; Andersson BA; Larsson S
Respir Med; 2000 Sep; 94(9):881-7. PubMed ID: 11001080
[TBL] [Abstract][Full Text] [Related]
10. Demonstration of C5 cleaving activity in bronchoalveolar fluids and cells: a mechanism of acute and chronic alveolitis.
Desai U; Dickey B; Varani J; Kreutzer DL
J Exp Pathol; 1984; 1(3):201-16. PubMed ID: 6400640
[TBL] [Abstract][Full Text] [Related]
11. Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells.
Mio T; Romberger DJ; Thompson AB; Robbins RA; Heires A; Rennard SI
Am J Respir Crit Care Med; 1997 May; 155(5):1770-6. PubMed ID: 9154890
[TBL] [Abstract][Full Text] [Related]
12. [The role of chemotactic factors in the pathogenesis of sarcoid granuloma formation].
Ohdama S
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Mar; 28(3):457-64. PubMed ID: 2214385
[TBL] [Abstract][Full Text] [Related]
13. Influence of smoking cessation on airway T lymphocyte subsets in COPD.
Roos-Engstrand E; Ekstrand-Hammarström B; Pourazar J; Behndig AF; Bucht A; Blomberg A
COPD; 2009 Apr; 6(2):112-20. PubMed ID: 19378224
[TBL] [Abstract][Full Text] [Related]
14. Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking.
Nowak D; Kasielski M; Antczak A; Pietras T; Bialasiewicz P
Respir Med; 1999 Jun; 93(6):389-96. PubMed ID: 10464820
[TBL] [Abstract][Full Text] [Related]
15. Identification of neutrophil chemotactic factors in bronchoalveolar lavage fluid of asthmatic patients.
Teran LM; Campos MG; Begishvilli BT; Schröder JM; Djukanovic R; Shute JK; Church MK; Holgate ST; Davies DE
Clin Exp Allergy; 1997 Apr; 27(4):396-405. PubMed ID: 9146932
[TBL] [Abstract][Full Text] [Related]
16. Chemotactic mediators of Th1 T-cell trafficking in smokers and COPD patients.
Brozyna S; Ahern J; Hodge G; Nairn J; Holmes M; Reynolds PN; Hodge S
COPD; 2009 Feb; 6(1):4-16. PubMed ID: 19229703
[TBL] [Abstract][Full Text] [Related]
17. Is there a correlation between the changes in the BAL fluid and cells in smokers and COLD patients and the lung function?
Huidekoper HJ; Kreukniet J; Terpstra GK; Wassink GA
Eur J Respir Dis Suppl; 1986; 146():233-8. PubMed ID: 3465550
[No Abstract] [Full Text] [Related]
18. Flow cytometric characterization of cell populations in bronchoalveolar lavage and bronchial brushings from patients with chronic obstructive pulmonary disease.
Hodge SJ; Hodge GL; Holmes M; Reynolds PN
Cytometry B Clin Cytom; 2004 Sep; 61(1):27-34. PubMed ID: 15351979
[TBL] [Abstract][Full Text] [Related]
19. Glutathione S-transferase omega in the lung and sputum supernatants of COPD patients.
Harju TH; Peltoniemi MJ; Rytilä PH; Soini Y; Salmenkivi KM; Board PG; Ruddock LW; Kinnula VL
Respir Res; 2007 Jul; 8(1):48. PubMed ID: 17617905
[TBL] [Abstract][Full Text] [Related]
20. Effect of an inhaled glucocorticoid on reactive oxygen species production by bronchoalveolar lavage cells from smoking COPD patients.
Verhoeven GT; Wijkhuijs AJ; Hooijkaas H; Hoogsteden HC; Sluiter W
Mediators Inflamm; 2000; 9(2):109-13. PubMed ID: 10958384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
